Association of artificially sweetened and sugar-sweetened soft drinks with β-cell function, insulin sensitivity, and type 2 diabetes: the Maastricht Study.


Journal

European journal of nutrition
ISSN: 1436-6215
Titre abrégé: Eur J Nutr
Pays: Germany
ID NLM: 100888704

Informations de publication

Date de publication:
Jun 2020
Historique:
received: 03 01 2019
accepted: 10 06 2019
pubmed: 6 9 2019
medline: 27 3 2021
entrez: 6 9 2019
Statut: ppublish

Résumé

Artificially sweetened and sugar-sweetened beverage consumptions have both been reported to be associated with type 2 diabetes mellitus (T2D) risk. The aim of the current study was to investigate the potential underlying associations with dynamic pancreatic β-cell function (BCF) and insulin sensitivity. We evaluated cross-sectional associations in 2240 individuals (mean ± SD age 59.6 ± 8.18, 49.4% male, 21.9% T2D) participating in a diabetes-enriched population-based cohort. Artificially sweetened and sugar-sweetened soft drinks and juice consumption were assessed by a food-frequency questionnaire. Glucose metabolism status, insulin sensitivity, and BCF were measured by a seven-point oral glucose tolerance test. Regression analyses were performed to assess associations of artificially and sugar-sweetened beverage consumption with measures of glucose homeostasis. Associations were adjusted for potential confounders, and additionally with and without total energy intake and BMI, as these variables could be mediators. Moderate consumption of artificially sweetened soft drink was associated with lower β-cell glucose sensitivity [standardized beta (95% CI), - 0.06 (- 0.11, - 0.02)], total insulin secretion [β - 0.06 (- 0.10, - 0.02)], and with lower β-cell rate sensitivity [odds ratio (95% CI), 1.29 (1.03, 1.62)] compared to abstainers. Daily artificially sweetened soft drink consumption was associated with lower β-cell glucose sensitivity [β - 0.05 (- 0.09, 0.00)], and total insulin secretion [β - 0.05 - 0.09, - 0.01)] compared to abstainers. Moderate and daily consumption of artificially sweetened soft drinks was associated with lower BCF, but not with insulin sensitivity. No evidence was found for associations of sugar-sweetened soft drink and juice consumption with BCF or insulin sensitivity in this middle-aged population. Prospective studies are warranted to further investigate the associations of artificially and sugar-sweetened beverage consumption with non-fasting insulin sensitivity and multiple BCF aspects.

Identifiants

pubmed: 31486878
doi: 10.1007/s00394-019-02026-0
pii: 10.1007/s00394-019-02026-0
pmc: PMC7230048
doi:

Substances chimiques

Insulin 0
Sweetening Agents 0

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1717-1727

Références

Eur J Epidemiol. 2017 May;32(5):363-375
pubmed: 28397016
Eur J Nutr. 2014 Feb;53(1):251-8
pubmed: 23575771
Am J Clin Nutr. 2011 Jun;93(6):1321-7
pubmed: 21430119
Physiol Behav. 2012 Nov 5;107(4):560-7
pubmed: 22583859
Am J Physiol Endocrinol Metab. 2002 Dec;283(6):E1159-66
pubmed: 12388151
JAMA. 2004 Aug 25;292(8):927-34
pubmed: 15328324
Diabetes Care. 2010 Nov;33(11):2477-83
pubmed: 20693348
Diabetes Care. 2009 Apr;32(4):688-94
pubmed: 19151203
Regul Toxicol Pharmacol. 2017 Aug;88:22-33
pubmed: 28502831
Diabetes Care. 1999 Sep;22(9):1462-70
pubmed: 10480510
J Nutr. 2016 Feb;146(2):290-7
pubmed: 26661840
Diabetes Obes Metab. 2008 Nov;10 Suppl 4:77-87
pubmed: 18834435
Am J Epidemiol. 2010 Mar 15;171(6):701-8
pubmed: 20160170
Eur J Clin Nutr. 2018 Mar;72(3):358-366
pubmed: 29235560
J Nutr. 2014 Jul;144(7):1099-105
pubmed: 24828025
BMJ. 2015 Jul 21;351:h3576
pubmed: 26199070
Diabetologia. 2003 Sep;46(9):1211-9
pubmed: 12879253
N Engl J Med. 1970 Jul 23;283(4):175-83
pubmed: 4912680
Br J Nutr. 2014 Sep 14;112(5):725-34
pubmed: 24932880
Curr Diabetes Rev. 2014 Jan;10(1):2-42
pubmed: 24524730
PLoS One. 2014 Mar 28;9(3):e93471
pubmed: 24682091
Am J Physiol Endocrinol Metab. 2007 Jul;293(1):E1-E15
pubmed: 17341552
Nutrition. 2019 Jun;62:39-46
pubmed: 30826598
Metabolism. 2014 Oct;63(10):1217-27
pubmed: 25070616
Physiol Behav. 2015 Dec 1;152(Pt B):450-5
pubmed: 26095119
Br J Math Stat Psychol. 2014 Nov;67(3):451-70
pubmed: 24188158
Am J Clin Nutr. 2013 Mar;97(3):517-23
pubmed: 23364017
Arch Intern Med. 2008 Jul 28;168(14):1487-92
pubmed: 18663160
Diabetes Care. 2012 Aug;35(8):1798-808
pubmed: 22778165
Circulation. 2016 Jan 26;133(4):370-7
pubmed: 26755505
Eur J Epidemiol. 2014 Jun;29(6):439-51
pubmed: 24756374
Circulation. 2007 Jul 31;116(5):480-8
pubmed: 17646581
J Sports Sci. 2016 Oct;34(19):1867-73
pubmed: 26837855
Diabetologia. 2017 Mar;60(3):432-441
pubmed: 27933333
J Clin Endocrinol Metab. 2005 Jan;90(1):493-500
pubmed: 15483086
J Nutr. 2007 Sep;137(9):2121-7
pubmed: 17709452
J Nutr. 2007 Jun;137(6):1447-54
pubmed: 17513405
Am J Clin Nutr. 2013 Jan;97(1):155-66
pubmed: 23151535
Diabet Med. 1994 Apr;11(3):286-92
pubmed: 8033528
Diabetologia. 2013 Jul;56(7):1520-30
pubmed: 23620057
BMC Med Res Methodol. 2011 Nov 23;11:158
pubmed: 22112229
Nature. 2014 Oct 9;514(7521):181-6
pubmed: 25231862
Am J Clin Nutr. 1997 Apr;65(4 Suppl):1220S-1228S; discussion 1229S-1231S
pubmed: 9094926
J Nutr. 2016 Dec;146(12):2544-2550
pubmed: 27934644

Auteurs

Louise J C J den Biggelaar (LJCJ)

Department of Epidemiology, Maastricht University, P.O. Box 616, 6200 MD, Maastricht, The Netherlands. louise.denbiggelaar@maastrichtuniversity.nl.
Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands. louise.denbiggelaar@maastrichtuniversity.nl.

Simone J S Sep (SJS)

Department of Rehabilitation Medicine, Maastricht University, Maastricht, The Netherlands.
Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands.

Andrea Mari (A)

C N R Institute of Neuroscience, Padua, Italy.

Ele Ferrannini (E)

C N R Institute of Clinical Physiology, Pisa, Italy.

Martien C J M van Dongen (MCJM)

Department of Epidemiology, Maastricht University, P.O. Box 616, 6200 MD, Maastricht, The Netherlands.
Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands.

Nicole E G Wijckmans (NEG)

Department of Epidemiology, Maastricht University, P.O. Box 616, 6200 MD, Maastricht, The Netherlands.
Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands.

Miranda T Schram (MT)

Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands.
Heart and Vascular Centre, Maastricht University Medical Centre+, Maastricht, The Netherlands.

Carla J van der Kallen (CJ)

Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands.

Nicolaas Schaper (N)

Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands.
Department of Rehabilitation Medicine, Maastricht University, Maastricht, The Netherlands.
Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands.

Ronald M A Henry (RMA)

Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands.
Heart and Vascular Centre, Maastricht University Medical Centre+, Maastricht, The Netherlands.

Marleen M van Greevenbroek (MM)

Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands.
Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands.

Coen D A Stehouwer (CDA)

Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands.

Simone J P M Eussen (SJPM)

Department of Epidemiology, Maastricht University, P.O. Box 616, 6200 MD, Maastricht, The Netherlands.
Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH